Influx Healthtech Limited
Influx Healthtech Limited, established in September 2020, specializes in contract manufacturing for B2B clients in nutraceuticals, cosmetics, and more, providing comprehensive services from product formulation to commercialization.
What Influx files
- Others24
- Investor Meet22
- Important10
- Board Meeting6
- Updates5
- PPTs2
Influx Healthtech delivered a strong FY26! Revenue jumped 40% to ₹146.8 Cr, EBITDA surged 45% to ₹29.9 Cr (20.3% margin), and PAT soared 54% to ₹20.5 Cr (14.0% margin). Nutraceuticals fueled 90% of growth. The company is strategically expanding capacity, aiming for a 2.5x increase, with significant CapEx planned for...
Influx Healthtech reported robust H1 FY26 earnings. Revenue from Operations grew 39% YoY to 66.8 Cr. EBIDTA surged 61% YoY to 14.7 Cr, expanding margins to 22.0%, while PAT increased 78% YoY to 10.0 Cr, reaching a 15.0% margin. Nutraceuticals remain the dominant segment, contributing 90% of revenue. The company...